Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cimaz

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Lupus|April 4, 2007
Overexpression of the antiapoptotic gene Bfl-1 in B cells from patients with familial systemic lupus erythematosusJ- M Andre, R Cimaz, B Ranchin, et al.
Annals of the Rheumatic Diseases|March 1, 2006
Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in uteroA Brucato, M G Astori, R Cimaz, et al.
Lupus|April 4, 2007
Response to tetanus vaccination in infants exposed in utero to immunosuppressants for maternal autoimmune disordersR Cimaz, E Meregalli, M Biggioggero, et al.
International Journal of Immunopathology and Pharmacology|January 16, 2010
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndromeL Cantarini, O M Lucherini, R Cimaz, et al.
International Journal of Immunopathology and Pharmacology|October 15, 2010
Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literatureL Cantarini, D Rigante, O M Lucherini, et al.
International Journal of Immunopathology and Pharmacology|January 20, 2011
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disordersL Cantarini, O M Lucherini, F Iacoponi, et al.
Arthritis and Rheumatism|October 3, 2000
Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter studyM L Bianchi, R Cimaz, M Bardare, et al.
Lupus|November 5, 2002
Pathogenetic associations of maternal anti-Ro/SSA antibodiesA Brucato, F Franceschini, A Doria, et al.
International Journal of Immunopathology and Pharmacology|April 30, 2014
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumabA Armuzzi, P Lionetti, C Blandizzi, et al.
International Journal of Immunopathology and Pharmacology|April 30, 2014
Adalimumab in the treatment of immune-mediated diseasesG Lapadula, A Marchesoni, A Armuzzi, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Lupus|April 4, 2007
Overexpression of the antiapoptotic gene Bfl-1 in B cells from patients with familial systemic lupus erythematosusJ- M Andre, R Cimaz, B Ranchin, et al.
Annals of the Rheumatic Diseases|March 1, 2006
Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in uteroA Brucato, M G Astori, R Cimaz, et al.
Lupus|April 4, 2007
Response to tetanus vaccination in infants exposed in utero to immunosuppressants for maternal autoimmune disordersR Cimaz, E Meregalli, M Biggioggero, et al.
International Journal of Immunopathology and Pharmacology|January 16, 2010
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndromeL Cantarini, O M Lucherini, R Cimaz, et al.
International Journal of Immunopathology and Pharmacology|October 15, 2010
Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literatureL Cantarini, D Rigante, O M Lucherini, et al.
International Journal of Immunopathology and Pharmacology|January 20, 2011
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disordersL Cantarini, O M Lucherini, F Iacoponi, et al.
Arthritis and Rheumatism|October 3, 2000
Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter studyM L Bianchi, R Cimaz, M Bardare, et al.
Lupus|November 5, 2002
Pathogenetic associations of maternal anti-Ro/SSA antibodiesA Brucato, F Franceschini, A Doria, et al.
International Journal of Immunopathology and Pharmacology|April 30, 2014
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumabA Armuzzi, P Lionetti, C Blandizzi, et al.
International Journal of Immunopathology and Pharmacology|April 30, 2014
Adalimumab in the treatment of immune-mediated diseasesG Lapadula, A Marchesoni, A Armuzzi, et al.
Pageof 11